Texas Roundup: Filament Labs, LiveOak, Capital Royalty, Alafair

5/22/14Follow @angelashah

Here is the latest innovation news from Texas:

—Austin, TX-based Filament Labs announced Thursday that it has raised $1 million in seed funding to develop an app that creates digital patient self-care programs with task reminders and educational information and videos. The round was led by Mercury Fund in Houston.

LiveOak Venture Partners closed Tuesday on its inaugural $109 million venture fund aimed at early-stage technology companies. The Austin-based firm began raising money in December and has so far invested in CS Disco, a Houston-based legal IT firm; StepOne, an Austin startup that has developed customer service software; and Veros Systems, which has predictive analytics software.

Capital Royalty in Houston also announced Tuesday that it and New Zealand-based Milford Active Growth Fund have collectively invested $14 million into AFT Pharmaceuticals, which is also based in New Zealand. Capital Royalty will also provide additional capital of up to $30 million in a structured loan facility to the 17-year-old drug company.

Alafair Biosciences last week received a $2 million grant from the Texas Emerging Technology Fund to further the development of the firm’s internal wound-healing devices. Alafair, which is based in Austin, licensed the technology from the University of Texas at Austin.

Angela Shah is the editor of Xconomy Texas. She can be reached at ashah@xconomy.com or (214) 793-5763. Follow @angelashah

By posting a comment, you agree to our terms and conditions.